Frontlight ResearchEarly access
Trial site
Institute of Clinical Oncology
- 6running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Metastatic breast cancer2 trials
- Deep vein thrombosis and pulmonary embolism1 trial
- Head and neck cancer1 trial
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 36 trials
- Phase 23 trials
- Status
- Active, not recruiting4 trials
- Completed2 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Regeneron Pharmaceuticals2 trials
- EMD Serono Research & Development Institute, Inc.1 trial
- Immuneering Corporation1 trial
- Immutep S.A.S.1 trial
- PharmaMar1 trial
- and 3 more
Running trials
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Recruiting
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Terminated
Completed
PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer
Site data: ClinicalTrials.govUpdated 12 Nov 2026